Sage gets big bump on postpartum depression data

Sage Therapeutics Inc. (NASDAQ:SAGE) jumped $12.56 (37%) to $46.21 on Tuesday, adding more than $400 million in market cap, after it said SAGE-547 met the

Read the full 259 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE